Perinatology and pediatric.Ukraine. 2017.4(72):37-40; doi 10.15574/PP.2017.72.37

Dubrov S. O., Lymanska A. Yu., Davydova Yu. V.
O.O. Bogomolets National Medical University, Kyiv, Ukraine
SI «Institute of Pediatrics, Obstetrics and Gynecology of NAMS of Ukraine», Kyiv, Ukraine

Objective: to show the therapeutic efficacy of saline solution with electrolytes and citicoline — Neurocitin (manufactured by «Yuria-Pharm») in pregnant women with vertigo mostly of vascular aetiology.
Material and methods. In total 29 pregnants, who had a clear diagnosis of the disease causing vertigo before pregnancy, were examined. In order to treat the vertiginous attacks, which significantly deteriorated the general status and quality of life, the women were administered Neurocitin (manufactured by «Yuria-Pharm») 100 ml intravenously infusion once daily during 10 days with crossover to citicoline in tablets then.
Results. During the study the therapeutic efficacy of Neurocitin (manufactured by «Yuria-Pharm») in pregnants with vertigo mostly of vascular aetiology was established.
Conclusions. Due to the frequent chronicity and prevalence of this pathology, particularly in pregnant women, attention should be paid to the optimization of its management. The safety profile and proven efficacy extends the indications for use of citicoline in pregnants with vertigo, both as monotherapy and, if necessary, combination therapy.
Key words: pregnancy, vertigo, vascular aetiology, Neurocitin.

References

1. Petrova D, Maslarov D, Angelov I, Zekin D. (2012). Analysis of therapeutic efficacy of citicoline in patients with vertigo of central origin and vascular aetiology. Am J Neuroprotec Neuroregen. 4; 1: 1—8. https://doi.org/10.1166/ajnn.2012.1043

2. Bustamante A, Giralt D, Garcia-Bonilla L et al. (2012). Citicoline in pre-clinical animal models of stroke: a meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial. J Neurochem. 123(2): 217—225. https://doi.org/10.1111/j.1471-4159.2012.07891.x; PMid:22845688

3. Davalos A, Alvarez-Sabin J, Castillo J et al. (2012). Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet. 380(9839): 349—357. https://doi.org/10.1016/S0140-6736(12)60813-7

4. Guilemany JM et al. (2004). Acta Otolaryngol. 124; 1: 49. https://doi.org/10.1080/00016480310002122

5. Nwaorgu OG et al. (2004). Neurol Sci. 25; 3; Suppl 1: 24.

6. Zalewski P et al. (2004). Otolaryngol Pol. 58; 1: 97.